6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

262-NETWORK CONTRACT OFFICE 22 (36C262)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26227Q0046

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

Tucson, AZ

SourceSAM
Documents4
The Department of Veterans Affairs, through its Network Contract Office 22 (NCO 22), has issued a Sources Sought notice for the procurement of Hemochron Signature Elite reagents and supplies. This notice, identified by procurement number 36C26227Q0046, seeks to identify potential sources capable of providing in-vitro diagnostic substances specifically tailored for use with the Hemochron Signature Elite system. The intended place of performance for this requirement is Tucson, Arizona. The scope of this procurement centers on the acquisition of reagents and supplies necessary for the operation of Hemochron Signature Elite devices, which are critical for point-of-care coagulation testing within VA medical facilities. The overarching objective is to ensure uninterrupted access to high-quality diagnostic materials that support patient care and clinical decision-making. Contractors responding to this notice should be able to supply products that meet the standards and specifications associated with in-vitro diagnostic substance manufacturing, as classified under NAICS code 325413 (2022 version) and Product Service Code 6550. Key requirements include the consistent provision of compatible reagents and supplies for the Hemochron Signature Elite system, with an emphasis on reliability, regulatory compliance, and timely delivery to the Tucson, AZ location. The VA is seeking information from qualified vendors who can demonstrate their capability to fulfill these needs over the contract lifecycle. This notice is a Sources Sought announcement, not a solicitation, and is intended to gather information about potential suppliers and their qualifications. There are no explicit set-aside requirements or special considerations detailed in the notice; however, interested parties are encouraged to review the attached documents for further specifications and instructions. The contracting entity is the Network Contract Office 22, a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is Rebecca Gaba, who can be reached via email at [email protected]. The notice remains active, with a response deadline set for November 2, 2026. Contractors evaluating this opportunity should consider their ability to supply in-vitro diagnostic substances for the Hemochron Signature Elite system, maintain compliance with VA standards, and deliver to the specified location in Tucson, AZ. For additional details and to access the attachments, interested parties should refer to the official notice on SAM.gov at https://sam.gov/opp/dc3833d21a044a32844ed5cf42e3fcf7/view.